These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
367 related items for PubMed ID: 27569045
21. Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis. Poshusta TL, Sikkink LA, Leung N, Clark RJ, Dispenzieri A, Ramirez-Alvarado M. PLoS One; 2009; 4(4):e5169. PubMed ID: 19365555 [Abstract] [Full Text] [Related]
22. Decreased amyloidogenicity caused by mutational modulation of surface properties of the immunoglobulin light chain BRE variable domain. Kobayashi Y, Tsutsumi H, Abe T, Ikeda K, Tashiro Y, Unzai S, Kamikubo H, Kataoka M, Hiroaki H, Hamada D. Biochemistry; 2014 Aug 12; 53(31):5162-73. PubMed ID: 25062800 [Abstract] [Full Text] [Related]
23. Pharmacological stabilization of the native state of full-length immunoglobulin light chains to treat light chain amyloidosis. Yan NL, Morgan GJ, Petrassi HM, Wilson IA, Kelly JW. Curr Opin Chem Biol; 2023 Aug 12; 75():102319. PubMed ID: 37279624 [Abstract] [Full Text] [Related]
24. Kinetic stability and sequence/structure studies of urine-derived Bence-Jones proteins from multiple myeloma and light chain amyloidosis patients. Blancas-Mejía LM, Martin EB, Williams A, Wall JS, Ramirez-Alvarado M. Biophys Chem; 2017 Nov 12; 230():89-98. PubMed ID: 28916410 [Abstract] [Full Text] [Related]
25. Role of complementarity-determining regions 1 and 3 in pathologic amyloid formation by human immunoglobulin κ1 light chains. Klimtchuk ES, Peterle D, Bullitt E, Connors LH, Engen JR, Gursky O. Amyloid; 2023 Dec 12; 30(4):364-378. PubMed ID: 37216473 [Abstract] [Full Text] [Related]
26. Kinetic control in protein folding for light chain amyloidosis and the differential effects of somatic mutations. Blancas-Mejía LM, Tischer A, Thompson JR, Tai J, Wang L, Auton M, Ramirez-Alvarado M. J Mol Biol; 2014 Jan 23; 426(2):347-61. PubMed ID: 24157440 [Abstract] [Full Text] [Related]
38. Amino acid sequence homology of monoclonal serum free light chain dimers and tissue deposited light chains in AL amyloidosis: a pilot study. Goldis R, Kaplan B, Arad M, Dispenzieri A, Dasari S, Kukuy OL, Simon AJ, Dori A, Shavit-Stein E, Ziv T, Murray D, Kourelis T, Gertz MA, Dominissini D, Magen H, Muchtar E. Clin Chem Lab Med; 2024 Feb 26; 62(3):464-471. PubMed ID: 37747270 [Abstract] [Full Text] [Related]
39. Effects of oxidative post-translational modifications on structural stability and self-assembly of λ6 immunoglobulin light chain. Zottig X, Laporte Wolwertz M, Golizeh M, Ohlund L, Sleno L, Bourgault S. Biophys Chem; 2016 Dec 26; 219():59-68. PubMed ID: 27744229 [Abstract] [Full Text] [Related]
40. Unfolded protein response activation reduces secretion and extracellular aggregation of amyloidogenic immunoglobulin light chain. Cooley CB, Ryno LM, Plate L, Morgan GJ, Hulleman JD, Kelly JW, Wiseman RL. Proc Natl Acad Sci U S A; 2014 Sep 09; 111(36):13046-51. PubMed ID: 25157167 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]